May 18, 2026 Tenders 0 Views

Tender Pharmacogenomic (PGx) Testing Service ulster university

Tender Pharmacogenomic (PGx) Testing Service ulster university 

Reference: 6532577

Description

The project wishes to appoint a suitable laboratory or multiple labs to supply an end-to-end genomic testing service which provides genomic variant data for n=4,854 participants in Northern Ireland (NI) and Ireland. Specifically, the areas where the project will recruit participants from of relevance to this tender includes counties Londonderry, Tyrone in Northern Ireland and counties Donegal and Sligo in Ireland. The iMPROVE project will operate on the basis of a research implementation study which aims to integrate pharmacogenomic testing into a patient-centred medicines optimisation care pathway in GP practices across the project regions. The new integrated care pathway will be led by GP practice pharmacists with a focus on medicines optimisation to improve outcomes, removing inappropriate and ineffective treatments and adverse drug event risk reduction. Medications for pain, depression, anxiety and cardiovascular disease are the most prescribed drugs which also display considerable variation in efficacy, in part due to single nucleotide polymorphisms (SNPs) in genes which can alter efficient drug metabolism. A laboratory service is required to transport participant samples from GP sites, test for a finite list of SNPs which alter the rate of metabolism of a constrained list of prescribed medications including opioids, SSRI’s, PPI’s, statins and Clopidgrel.

Total value (estimated)

  • £600,000 excluding VAT
  • £720,000 including VAT

Above the relevant threshold

Contract dates (estimated)

  • 3 August 2026 to 2 August 2028
  • Possible extension to 3 August 2030
  • 4 years, 1 day

 

Description of possible extension:

Any periods up to 24 months

Main procurement category

Services

CPV classifications

  • 85140000 – Miscellaneous health services
  • 85145000 – Services provided by medical laboratories
  • 85148000 – Medical analysis services
  • 71900000 – Laboratory services

Participation

Legal and financial capacity conditions of participation

This procurement is conducted in accordance with the requirements of Article 8 of the

Financing Agreement establishing the PEACEPLUS Programme for 2021-2027, which

requires the procurement procedures under Articles 181 and 182 of Regulation (EU,

Euratom) 2024/2509 to be applied


Submission

Enquiry deadline

11 June 2026, 3:00pm

Tender submission deadline

17 June 2026, 3:00pm

Submission address and any special instructions

Tenders may be submitted electronically

Yes

Languages that may be used for submission

English

Award decision date (estimated)

3 August 2026


Award criteria

This table contains award criteria for this lot
Name Type Weighting
Quallity Quality 60%
Price Price 40%

Other information

Description of risks to contract performance

This procurement is conducted in accordance with the requirements of Article 8 of the

Financing Agreement establishing the PEACEPLUS Programme for 2021-2027, which

requires the procurement procedures under Articles 181 and 182 of Regulation (EU,

Euratom) 2024/2509 to be applied. Any potential

applicant for review of any decisions taken in connection with the procurement should

seek their own advice in connection with review procedures, but jurisdiction in connection

with such a review is likely to be with the High Court of Justice, by way of a claim for

judicial review or otherwise.

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Open procedure

Justification for not publishing a preliminary market engagement notice

N/A


Contracting authority

ulster university

  • Companies House: RC000726

Finance Office

Coleraine

BT521SA

United Kingdom

Region: UKN0C – Causeway Coast and Glens

Organisation type: Public authority – sub-central government

Devolved regulations that apply: Northern Ireland

Leave a Comment

Your email address will not be published. Required fields are marked *